Licensing in the pharmaceutical industry: trends and strategies

  • META KODRIČ University of Ljubljana, Faculty of Chemistry and Chemical Technology, Vecna pot 113, 1000 Ljubljana, Slovenia.
  • JONA NOVLJAN University of Ljubljana, Biotechnical Faculty, Jamnikarjeva ulica 101, 1000 Ljubljana, Slovenia.
  • DOMEN PREGELJC Institute of Molecular Physical Science, Department of Chemistry and Applied Biosciences, ETH Zurich, Vladimir-Prelog-Weg 2, 8093 Zurich, Switzerland.
  • JURE REBSELJ University of Ljubljana, Biotechnical Faculty, Jamnikarjeva ulica 101, 1000 Ljubljana, Slovenia. https://orcid.org/0009-0002-3737-026X
  • MARTIN RIHTARŠIČ University of Ljubljana, Faculty of Chemistry and Chemical Technology, Vecna pot 113, 1000 Ljubljana, Slovenia. https://orcid.org/0000-0002-7108-5553
  • ZDENKO ČASAR University of Ljubljana, Faculty of Pharmacy, Askerceva 7, 1000 Ljubljana, Slovenia. https://orcid.org/0000-0002-6689-3353
Keywords: innovations, in-licensing, out-licensing, mergers and acquisitions, pharmaceutical industry

Abstract

The future of pharmaceutical companies is closely tied to their ability to innovate, traditionally achieved within the company. Due to declining productivity in recent decades, companies are shifting toward open business models and external collaboration. Partnerships between large and small industry players facilitate the exchange of ideas, knowledge, capital, and technology, accelerating the development of new drugs. Licensing plays a key role in this, including in- and out-licensing as well as licensing of university technologies. In addition to licensing, mergers and acquisitions are also significant, as different forms of collaboration enhance innovation in the pharmaceutical industry, benefiting both companies and patients.

Downloads

Download data is not yet available.

Author Biographies

META KODRIČ, University of Ljubljana, Faculty of Chemistry and Chemical Technology, Vecna pot 113, 1000 Ljubljana, Slovenia.

META KODRIČ

University of Ljubljana, Faculty of Chemistry and Chemical Technology, Vecna pot 113, 1000 Ljubljana, Slovenia.

E-mail: meta.kodric1@gmail.com

JONA NOVLJAN, University of Ljubljana, Biotechnical Faculty, Jamnikarjeva ulica 101, 1000 Ljubljana, Slovenia.

JONA NOVLJAN

University of Ljubljana, Biotechnical Faculty, Jamnikarjeva ulica 101, 1000 Ljubljana, Slovenia.

E-mail: jo.novljan@gmail.com

DOMEN PREGELJC, Institute of Molecular Physical Science, Department of Chemistry and Applied Biosciences, ETH Zurich, Vladimir-Prelog-Weg 2, 8093 Zurich, Switzerland.

DOMEN PREGELJC

Institute of Molecular Physical Science, Department of Chemistry and Applied Biosciences, ETH Zurich, Vladimir-Prelog-Weg 2, 8093 Zurich, Switzerland.

E-mail: dpregeljc@ethz.ch

JURE REBSELJ, University of Ljubljana, Biotechnical Faculty, Jamnikarjeva ulica 101, 1000 Ljubljana, Slovenia.

JURE REBSELJ

University of Ljubljana, Biotechnical Faculty, Jamnikarjeva ulica 101, 1000 Ljubljana, Slovenia.

E-mail: jure.rebselj@gmail.com

MARTIN RIHTARŠIČ, University of Ljubljana, Faculty of Chemistry and Chemical Technology, Vecna pot 113, 1000 Ljubljana, Slovenia.

MARTIN RIHTARŠIČ

University of Ljubljana, Faculty of Chemistry and Chemical Technology, Vecna pot 113, 1000 Ljubljana, Slovenia.

E-mail: martin.rihtarsic@hotmail.com

ZDENKO ČASAR, University of Ljubljana, Faculty of Pharmacy, Askerceva 7, 1000 Ljubljana, Slovenia.

ZDENKO ČASAR

University of Ljubljana, Faculty of Pharmacy, Askerceva 7, 1000 Ljubljana, Slovenia.

E-mail: zdenko.casar@ffa.uni-lj.si

Published
2024-12-19
How to Cite
KODRIČ M., NOVLJAN J., PREGELJC D., REBSELJ J., RIHTARŠIČ M., & ČASAR Z. (2024). Licensing in the pharmaceutical industry: trends and strategies. Anali PAZU HD, 10(1-2), 47-87. https://doi.org/10.18690/analipazuhd.10.1-2.47-87.2024